🧬 Patient Journey: Multiple Sclerosis — regained strength and restored independence

👤 Patient Profile: Silvia Baistrocchi, 56 — Italy

Diagnosis: Secondary Progressive Multiple Sclerosis (SPMS)

Silvia, a 56-year-old woman from Italy, had been living with secondary progressive multiple sclerosis. Due to advanced motor impairment and generalised weakness, she had become wheelchair-dependent. She also experienced chronic fatigue and increasing difficulty with basic daily activities.

🧬 Clinical Approach at BioCells Medical

In May 2024, Silvia began a fully personalised allogeneic regenerative therapy protocol at BioCells Medical, focused on stabilising her condition and restoring motor capacity.

Her treatment programme included:

• Intravenous infusion of mesenchymal stem cells (MSCs)

• Intranasal administration of MSCs and purified exosomes

• Nebulised inhalation therapy with regenerative biofactors

To reinforce the effects, Silvia received two additional MSC booster infusions in the following months — spaced apart to build cumulative therapeutic momentum.

📈 Observed Results

According to both her family and physiotherapy team, Silvia began showing progressive and meaningful improvement:

• Increased muscle strength, especially in her lower limbs

• Greater endurance during physiotherapy sessions

• Regained ability to stand up from the wheelchair and take a few steps with assistance

• Remarkably, she maintained these improvements even after a prolonged intestinal infection in December 2024 — recovering faster than expected

This post-infection resilience was considered a sign of a stronger systemic baseline, likely reinforced by the regenerative protocol.

🔁 Follow-Up

Silvia remains under medical observation and continues structured physical therapy. Since her last booster treatment, no further deterioration has been reported, and her family notes a significant improvement in overall quality of life and autonomy.

🌍 About This Programme

BioCells Medical provides stage-adjusted regenerative care for patients with multiple sclerosis — including progressive forms.Each programme may include MSCs, exosomes, T-regulatory cells, peptides, and neurostimulation, all prepared in our certified GMP laboratory in Warsaw.

Treatment can be delivered either in-clinic or via international deployment, depending on patient needs.

📩 Every case is unique — and so is the potential for improvement.→ Book a free online consultation with our doctors to discuss what may be possible in your case.